Drew Weismann Speaks on the Future of mRNA Technology in Bloomberg’s “The Big Take” Podcast

Drew Weismann, M.D., Ph.D., who is known for co-inventing the mRNA technology that enabled the rapid development of highly effective COVID-19 vaccines with his colleague Katalin Karikó at Penn, recently joined an episode of Bloomberg podcast “The Big Take” to talk about his discovery and the impact of mRNA technology on the development of therapies for flu, cancer and rare genetic diseases.

Bloomberg biosecurity reporter Riley Griffin discusses Pfizer’s next phase of developing mRNA vaccines, and Bloomberg’s chief medical writer Robert Langreth forecasts how this technology could transform treatment for a variety of illnesses. Listen here.

Skip to content